A survey of new Rx, new OTC, new indications, and new generics
October 13, 2008
By:
Lisa B. Samalonis
|
FDA has approved Xenazine from Prestwick Pharmaceuticals for treatment of chorea in Huntington's disease. It is the first medication to treat any symptom of the disease.
October 13, 2008
By:
Julio Fernandez, Pharm.D.
|
Previous medication therapies for diabetes were limited to insulin, sulfonylureas, and metformin. Promising new approaches include DPP-IV inhibitors, GLP-1 analogues, and SGLT-2 inhibitors.
October 13, 2008
By:
Julio Fernandez, Pharm.D.
|
CleviprexTM is the first new IV antihypertensive treatment to be approved by the FDA in 10 years.
October 13, 2008
By:
Fred Gebhart, Contributing Editor
|
In addition to syringes and insulin vials, products already on the market or in the works include insulin pens, pumps, patches, sprays, and inhaled and oral insulin.
FDA has approved clotrimazole cream USP 1 percent for treatment of skin itching or burning.
A survey of new drugs, new indications, new formulations, new generics, new OTC, and new HBC.
A survey of new drugs, new indications, new formulations, new generics, new OTC, and new products.
September 15, 2008
By:
Anthony Vecchione
|
A new label design from PharMEDium should make a medication's name and dose easier to read and recognize. The enhanced labeling will be applied first to four patient-controlled, IV pain-management drugs as well as local anesthetics for nerve-block therapy.
